• October 20, 2020

    FineHeart Achieves Milestone for its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study

    Bordeaux, France - October 20, 2020. – FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of...

    Read More
  • July 22, 2020

    FineHeart: An LVAD Works in Synchrony with the Heart

    Founded by electrophysiologists, FineHeart has developed an LVAD that is like no other. It resides inside the left ventricle of the heart where it times the blood flow it generates with the opening an...

    Read More
  • June 12, 2020

    ZZ Biotech Announces FDA Fast Track Designation for Stroke Program

    HOUSTON, USA, June 12, 2020 / B3C newswire / -- ZZ Biotech today announced that the US Food and Drug Administration (FDA) has designated the investigation of the company’s experimental drug 3K3A-APC...

    Read More
  • May 27, 2020

    Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury

    CAMBRIDGE, Mass., May 27, 2020 /PRNewswire/ -- Kantum Pharma Inc. (Kantum), a biopharmaceutical company focused on developing therapies for the prevention and treatment of damaging inflammation trigge...

    Read More
  • May 5, 2020

    FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure

    Bordeaux, May 5, 2020 – FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS),...

    Read More
  • May 7, 2020

    Acesion Pharma Strengthens Clinical Team with Key Appointments

    Copenhagen, 5 May 2020. Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recru...

    Read More
  • April 28, 2020

    AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

    April 28, 2020 SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, in...

    Read More
  • March 23, 2020

    CroíValve announces successful first human use of its Duo Tricuspid Coaptation Valve technology

    Dublin, Ireland, 23 March 2020 - CroíValve announced today the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The procedure was performed by an expe...

    Read More
  • February 24, 2020

    Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board

    Philadelphia, PA, February 24, 2020 – Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-based treatments for cardiovascular disease, tod...

    Read More
  • February 6, 2020

    Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

    February 06, 2020 07:00 AM Eastern Standard Time SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced tha...

    Read More